Real-time enrollment status for this lymphoma, primary effusion clinical trial
Current Status
Recruiting
Checked: July 21, 2026 at 5:37 AM UTC
| NCT Number | NCT05907759 |
| Recruiting Status | Recruiting |
| Condition | Lymphoma, Primary Effusion |
| Phase | PHASE2 |
| Target Enrollment | 28 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | July 6, 2026 (2 weeks ago) |
As of July 21, 2026: Clinical trial NCT05907759 is currently recruiting participants. This phase2 study for lymphoma, primary effusion is actively seeking new participants at 1 location across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05907759 is actively recruiting participants as of July 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05907759 was last updated 2 weeks ago (July 6, 2026). HelloStudys verifies this status automatically.